
Another week passes by, and the headlines have seen some shocking stories, such as the news that the UK is …

Celgene is celebrating following NICE’s announcement that it had decided to recommend the use of nab-Paclitaxel, when used in combination …

Facebook CEO Mark Zuckerberg and philanthropist Priscilla Chan have continued their quest to improve worldwide healthcare with the latest donation …

Janssen has announced that it has suffered a knockback to its plans to commercialise sirukumab in the US in the …

Findings by researchers at the University of Sheffield have indicated that thousands of pounds could be saved in blood cancer …

The FDA has given its approval for the commercialisation of Celgene and Agios Pharmaceutical’s Idhifa for the treatment of relapsed …

The uncertainty caused by Brexit has been and continues to be far-reaching, and perhaps most impactful for business, organisations and …

It’s been a rollercoaster week for AstraZeneca.

As of today, all babies born in the UK will be administered with the vaccine for hepatitis B, with the …

Last month saw the formation of the Brexit Health Alliance, a partnering of key pharma and life sciences organisations including …

Mylan and Biocon have revealed that their biosimilar version of Roche and Genentech’s Herceptin (trastuzumab) has received unanimous recommendation from …

As the week comes to a close, we bring you the stories that were most read by our readers – …

When they first came along, webinars were the equivalent of an outside broadcast unit, lots of hardware, dedicated studios and …

The government has announced its response to Dame Fiona Caldicott’s 2016 data security review and in the wake of the …

The pharmaceutical and life sciences industries have stressed the importance of cooperation between the EU and the UK in order …